Erythropoietin in the treatment of cancer

Onkologie. 2005 Apr;28(4):181-2. doi: 10.1159/000084038.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic*
  • Erythropoietin / therapeutic use*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / mortality*
  • Prognosis
  • Risk Assessment / methods*
  • Risk Factors
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Erythropoietin